Q32 Bio (QTTB) Revenue & Revenue Breakdown
Q32 Bio Revenue Highlights
00
Q32 Bio Revenue by Period
Q32 Bio Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | - | 100.00% |
| 2024-12-31 | - | -100.00% |
| 2023-12-31 | $-6.65M | -200.00% |
| 2022-12-31 | $6.65M | -80.42% |
| 2021-12-31 | $33.97M | 1157.25% |
| 2020-12-31 | $2.70M | 62.18% |
| 2019-12-31 | $1.67M | -68.70% |
| 2018-12-31 | $5.32M | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | - |
Q32 Bio generated - in revenue during NA 2025, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Q32 Bio Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-03-31 | - | -100.00% |
| 2025-12-31 | $53.74M | 100.00% |
| 2025-09-30 | - | 100.00% |
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $-14.66M | -888.70% |
| 2023-09-30 | $1.86M | -42.00% |
| 2023-06-30 | $3.21M | 8.75% |
| 2023-03-31 | $2.95M | 267.46% |
| 2022-12-31 | $802.00K | - |
| 2022-09-30 | $802.00K | - |
| 2022-06-30 | $802.00K | - |
| 2022-03-31 | $802.00K | - |
| 2021-12-31 | $802.00K | -52.18% |
| 2021-09-30 | $1.68M | -23.32% |
| 2021-06-30 | $2.19M | -92.54% |
| 2021-03-31 | $29.30M | 2890.31% |
| 2020-12-31 | $980.00K | 72.84% |
| 2020-09-30 | $567.00K | - |
| 2020-06-30 | $567.00K | -3.57% |
| 2020-03-31 | $588.00K | 4.44% |
| 2019-12-31 | $563.00K | 27.66% |
| 2019-09-30 | $441.00K | 12.50% |
| 2019-06-30 | $392.00K | 45.19% |
| 2019-03-31 | $270.00K | -72.45% |
| 2018-12-31 | $980.00K | 2.71% |
| 2018-09-30 | $954.15K | 2.99% |
| 2018-06-30 | $926.48K | 12.52% |
| 2018-03-31 | $823.37K | - |
Q32 Bio generated - in revenue during Q1 2026, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Q32 Bio Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| VRCA | Verrica Pharmaceuticals | $35.58M | $5.02M |
| GBIO | Generation Bio | $19.89M | $765.00K |
| SONN | Sonnet BioTherapeutics | $1.00M | - |
| ANTX | AN2 Therapeutics | - | - |
| ITRM | Iterum Therapeutics | - | $390.00K |
| SABS | SAB Biotherapeutics | - | - |
| BOLD | Boundless Bio | - | - |
| INTS | Intensity Therapeutics | - | - |
| NXTC | NextCure | - | - |
| QTTB | Q32 Bio | - | - |
| PSTV | Plus Therapeutics | - | $1.03M |